search
SLS
Trends
- 1Stock Futures Climb Ahead of AMD Results as Palantir Rally Continues▼Nasdaq, S&P 500 Futures Climb As Wall Street Awaits AMD, SpaceX Earnings After Palantir Rally: Why SNAP, AMZN, SNDK, LCID, SLS, ASTS Are In Focus
Nasdaq and S&P 500 futures are rising as Wall Street awaits earnings from AMD and SpaceX following a strong Palantir rally. Traders are also watching SNAP, Amazon, SanDisk, Lucid, Sls and AST SpaceMobile, with several stocks in focus for further moves after recent gains in tech and space-related names.
- 2
Brazilian skateboarder Rayssa Leal is in action at the Street League Skateboarding stop in Paris, and fans are checking the full schedule and broadcast times. Estadão published a guide with the complete program, timings and where to watch the event live, drawing attention from Brazilian followers of the Olympic medalist.
- 3Retail Traders Eye SLS and IBRX After Moderna Joins Nasdaq-100●SLS, IBRX Stocks Draw Retail Chatter As MRNA Lands A Nasdaq-100 Spot – ‘It Will Be SLS Next’
Retail traders are speculating that Sellas Life Sciences (SLS) and ImmunityBio (IBRX) could be the next biotech stocks to gain a Nasdaq-100 inclusion after Moderna (MRNA) landed a spot in the index. Some investors are voicing confidence that SLS will follow, fueling chatter and speculative buying around the smaller biotech names.
- 4SLS and IBRX climb as Moderna joins Nasdaq-100▼SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot
SLS and IBRX shares rose in overnight trading while retail investors turned their attention to Moderna after the biotech was added to the Nasdaq-100 index. Traders are watching whether Moderna's inclusion sparks a broader rally in biotech names, with retail chatter focused on momentum across MRNA and related small-cap stocks heading into the next session.
- 5St. Louis firms announce new executive appointments●People in Business: SLSO appoints; CMIT names; UniGroup adds; Le Meridien appoints
Several St. Louis-area organizations have announced personnel moves: the St. Louis Symphony Orchestra has made an appointment, CMIT has named a new figure, UniGroup has added to its team, and Le Meridien has made a new appointment. The roundup of local business appointments was published in the St. Louis Post-Dispatch's People in Business column.
- 6SLS Stock Jumps Overnight On AML Survival Data●SLS Stock Rises Overnight: Retail Traders Call New AML Survival Data 'Huge' Ahead Of CEO’s Fox Appearance
Shares of SLS, the biotech behind AML-focused treatment candidates, rose in overnight trading after new survival data drew enthusiasm from retail traders, who described the results as 'huge'. Attention is also building ahead of a scheduled CEO interview on Fox, which investors expect could amplify the stock's momentum. Traders are watching for confirmation of the data and further company commentary.
- 7Retail biotech favorites SLS, IBRX, VNDA, IOVA vs September slump▼Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump?
Biotech stocks lagged the broader market in September, with the SPDR S&P Biotech ETF (XBI) falling while the wider market held up better. Attention is now on whether retail-favored names SELLAS Life Sciences (SLS), ImmunityBio (IBRX), Vanda Pharmaceuticals (VNDA) and Iovance Biotherapeutics (IOVA) managed to escape the sector's slump. Investors are weighing whether these popular small-cap biotechs diverged from the wider sector weakness.
- 8Japanese cram school says autumn of second high school year decides med school success●https://www. gotorola.com/553101/ 【高2の秋が勝負】医学部合格者が語る「受かる高2生」と「危ない高2生」の決定的な違い # 2次試験 # Entertainment # march # UCXErsls7Y
A Japanese university-prep cram school, Takeda Juku, is telling students that the autumn of their second year of high school is the decisive period for medical school admissions, outlining the difference between students likely to pass and those at risk. Successful medical school entrants share study methods, advice on the common test and secondary exams, and tips for national and top private universities like Keio and Waseda.
- 9Sellas Shares End Three-Quarter Winning Streak●SLS Stock Snaps 3-Quarter Winning Streak — Why Retail Traders Are Watching Sellas’ Lease And AML Pipeline
Sellas Life Sciences shares have broken a three-quarter run of gains, drawing attention from retail traders. Discussion is centered on the company's lease situation and its pipeline of AML-focused drug candidates, which investors see as key to whether the stock can resume its climb after the streak-ending pullback.